CRON Stock Overview
Cronos Group Inc. operates as a cannabinoid company.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for CRON from our risk checks.
My Notes
NewNotes are coming soon
Cronos Group Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$3.26 |
| 52 Week High | CA$5.36 |
| 52 Week Low | CA$3.21 |
| Beta | 1.31 |
| 1 Month Change | -5.23% |
| 3 Month Change | -12.13% |
| 1 Year Change | -31.08% |
| 3 Year Change | -64.14% |
| 5 Year Change | -65.32% |
| Change since IPO | 292.77% |
Recent News & Updates
Recent updates
A Look At The Intrinsic Value Of Cronos Group Inc. (TSE:CRON)
Oct 12
We're Not Very Worried About Cronos Group's (TSE:CRON) Cash Burn Rate
Sep 10Cronos Group Inc. (TSE:CRON) Consensus Forecasts Have Become A Little Darker Since Its Latest Report
Aug 12We Think Cronos Group (TSE:CRON) Can Afford To Drive Business Growth
May 19Is Cronos Group Inc. (TSE:CRON) Trading At A 47% Discount?
Jul 29An Intrinsic Calculation For Cronos Group Inc. (TSE:CRON) Suggests It's 29% Undervalued
Apr 08Have Insiders Sold Cronos Group Inc. (TSE:CRON) Shares Recently?
Mar 04What You Need To Know About Cronos Group Inc.'s (TSE:CRON) Investor Composition
Jan 22
Does Cronos Group's (TSE:CRON) Statutory Profit Adequately Reflect Its Underlying Profit?
Dec 18Shareholder Returns
| CRON | CA Pharmaceuticals | CA Market | |
|---|---|---|---|
| 7D | -3.0% | 1.7% | -1.0% |
| 1Y | -31.1% | -61.7% | -4.4% |
Return vs Industry: CRON exceeded the Canadian Pharmaceuticals industry which returned -61.7% over the past year.
Return vs Market: CRON underperformed the Canadian Market which returned -4.4% over the past year.
Price Volatility
| CRON volatility | |
|---|---|
| CRON Average Weekly Movement | 7.0% |
| Pharmaceuticals Industry Average Movement | 14.0% |
| Market Average Movement | 9.8% |
| 10% most volatile stocks in CA Market | 18.9% |
| 10% least volatile stocks in CA Market | 3.8% |
Stable Share Price: CRON is not significantly more volatile than the rest of Canadian stocks over the past 3 months, typically moving +/- 7% a week.
Volatility Over Time: CRON's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2012 | 626 | Mike Gorenstein | https://www.thecronosgroup.com |
Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones and Happy Dance brands in the United States. The company is also involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets.
Cronos Group Inc. Fundamentals Summary
| CRON fundamental statistics | |
|---|---|
| Market Cap | CA$1.24b |
| Earnings (TTM) | -CA$300.43m |
| Revenue (TTM) | CA$127.46m |
9.7x
P/S Ratio-4.1x
P/E RatioIs CRON overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CRON income statement (TTM) | |
|---|---|
| Revenue | US$94.81m |
| Cost of Revenue | US$80.67m |
| Gross Profit | US$14.15m |
| Other Expenses | US$237.63m |
| Earnings | -US$223.49m |
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.59 |
| Gross Margin | 14.92% |
| Net Profit Margin | -235.72% |
| Debt/Equity Ratio | 0% |
How did CRON perform over the long term?
See historical performance and comparison